Comprehensive immune profiling of patients with advanced urothelial or renal cell carcinoma receiving immune checkpoint blockade

Immune checkpoint inhibitors (ICI) are used in the treatment of urothelial and renal cell cancers. While some patients may have exceptional responses, better predictive biomarkers are needed. We profiled the circulating immune compartment of patients receiving ICI to identify possible immune markers...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavoie, Jean-Michel, Baichoo, Priya, Chavez, Elizabeth, Nappi, Lucia, Khalaf, Daniel, Kollmannsberger, Christian K., Chi, Kim N., Weng, Andrew, Steidl, Christian, Eigl, Bernhard J., Nissen, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513023/
https://www.ncbi.nlm.nih.gov/pubmed/36176410
http://dx.doi.org/10.3389/fonc.2022.973402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513023/
https://www.ncbi.nlm.nih.gov/pubmed/36176410
http://dx.doi.org/10.3389/fonc.2022.973402

Ejemplares similares